A Real World Study to Assess the Effectiveness of Switching to Once Daily Closed Triple Therapy from Mono/Dual Combination or Open Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease.

International Journal of Chronic Obstructive Pulmonary Disease
Wei-Chun HuangWen-Chien Cheng

Abstract

This real world study evaluated the effectiveness of switching to closed triple therapy from mono/dual combination or open triple therapy in patients with chronic obstructive pulmonary disease (COPD). We conducted this retrospective study at a single medical center from December 2014 to September 2020. Patients with COPD who were stepped up to triple therapy were enrolled. We analyzed the duration from initial COPD management to open or closed triple therapy and identified the clinical predictors of the patients who needed triple therapy early. We also evaluated the effectiveness of triple therapy after switching from initial management, and closed triple therapy after switching from open triple therapy. A total 115 COPD patients who were stepped up to triple therapy from initial treatment were analyzed. The duration from initial treatment to triple therapy was 22.4 months. The baseline peripheral blood eosinophil counts of the patients who switched to triple therapy early (n=63, less than 22 months) and those who switched to triple therapy later (n=52, more than 22 months) were similar (489.6 vs 434.5 cells/uL; p=0.589). After univariate and multivariate analysis, the patients who were older had more acute exacerbations (AEs) ...Continue Reading

References

Aug 30, 2008·Thorax·J Bourbeau, S J Bartlett
Oct 7, 2011·Respiratory Medicine·Ki Suck JungUNKNOWN Korea Chronic Obstructive Pulmonary Disease study group
Nov 2, 2011·Respiratory Medicine·Nicola A HananiaDennis E Niewoehner
Jun 18, 2015·International Journal of Chronic Obstructive Pulmonary Disease·Masaki MiyazakiUNKNOWN Keio COPD Comorbidity Research (K-CCR) group
Nov 4, 2015·International Journal of Chronic Obstructive Pulmonary Disease·Guy BrusselleRupert C Jones
Jan 6, 2017·International Journal of Chronic Obstructive Pulmonary Disease·Jason C SimeoneTeresa K Wilcox
Apr 5, 2017·American Journal of Respiratory and Critical Care Medicine·David A LipsonSteven J Pascoe
Apr 19, 2018·The New England Journal of Medicine·David A LipsonUNKNOWN IMPACT Investigators
May 26, 2018·Respiratory Care·Maureen George
Sep 11, 2018·International Journal of Chronic Obstructive Pulmonary Disease·Roland BuhlHeinrich Worth
Oct 21, 2018·BMC Pulmonary Medicine·Magdalena HumenbergerBernd Lamprecht
Feb 19, 2019·ERJ Open Research·Lowie E G W VanfleterenLeonardo M Fabbri
May 8, 2019·Chronic Obstructive Pulmonary Diseases : Journal of the COPD Foundation·Robert M Marron, Maria Elena Vega Sanchez
Jun 25, 2019·International Journal of Clinical Pharmacology and Therapeutics·Yoshihisa IshiuraShosaku Nomura
Sep 2, 2020·Cleveland Clinic Journal of Medicine·Yael Mauer, Rachel Metzger Taliercio
Dec 31, 2020·International Journal of Chronic Obstructive Pulmonary Disease·Wen-Chien ChengWu-Huei Hsu

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Software Mentioned

INTREPID
MedCalc

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Related Papers

European Journal of Clinical Investigation
Valentina PecoraroTommaso Trenti
International Journal of Chronic Obstructive Pulmonary Disease
Andriana I PapaioannouNikos Tzanakis
© 2021 Meta ULC. All rights reserved